Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies

E-ISSN： 2212-3970|4|1|9-18

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.4, Iss.1, 2009-01, pp. : 9-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Anti-HER2 Cancer Therapy in Elderly Women Diagnosed with Breast Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 639-645

Bentham Science Publishers

Access to resources Recommend Favorite

New Gene Therapy Strategies for Cancer Treatment: A Review of Recent Patents

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 3, 2012-09 ,pp. : 297-312

Bentham Science Publishers

Access to resources Recommend Favorite

State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 2, 2012-01 ,pp. : 207-217

Bentham Science Publishers

Access to resources Recommend Favorite

HER2-Positive Breast Cancer: Current Treatment Strategies

By Perez Edith Baweja Mansoina

Cancer Investigation, Vol. 26, Iss. 6, 2008-07 ,pp. : 545-552

Informa Healthcare

Access to resources Recommend Favorite

Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

By Payne Kyle Zoon Christine Wan Wen Marlar Khin Keim Rebecca Kenari Mehrab Kazim A. Bear Harry Manjili Masoud

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 45-57

Springer Publishing Company

Access to resources Recommend Favorite